Company: SHPH
Filing Date: 2025-03-05
Form Type: S-1/A
Source: 0001493152-25-009106
Chunk: 62

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-03-05
Form: S-1/A
Chunk 62
---
 in our best interests, including transactions that might result in a premium over the market price for our shares.

These provisions, summarized below, are expected to discourage coercive takeover practices and inadequate takeover bids. These provisions are also designed to encourage persons seeking to acquire control of us to first negotiate with our Board of Directors. We believe that the benefits of increased protection of our potential ability to negotiate with the proponent of a non-friendly or unsolicited proposal to acquire or restructure us outweigh the disadvantages of discouraging these proposals because negotiation of these proposals could result in an improvement of their terms.

Delaware Anti-Takeover Statute

In general, Delaware corporations are subject to Section 203 of the DGCL, which prohibits a Delaware corporation from engaging in any business combination with any interested stockholder for a period of three years after the date that such stockholder became an interested stockholder, with the following exceptions:

| ● | before                                                                                                                                   
 such date, the board of directors of the corporation approved either the business combination or the transaction that resulted in        
 the stockholder becoming an interested holder;                                                                                           |
| ● | upon                                                                                                                                     
 completion of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned      
 at least 85% of the voting stock of the corporation outstanding at the time the transaction began, excluding for purposes of determining 
 the voting stock outstanding (but not the outstanding voting stock owned by the interested stockholder) those shares owned (i) by        
 persons who are directors and also officers and (ii) employee stock plans in which employee participants do not have the right to        
 determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer;                         |

| ● | on                                                                                                                                        
 or after such date, the business combination is approved by the board of directors and authorized at an annual or special meeting         
 of the stockholders, and not by written consent, by the affirmative vote of at least 662/3% of the outstanding                            
 voting stock that is not owned by the interested stockholder; or                                                                          |
| ● | the                                                                                                                                       
 corporation does not have a class of voting stock that is: (i) listed on a national securities exchange; or (ii) held of record by        
 more than 2,000 stockholders, unless any of the foregoing results from action taken, directly or indirectly, by an interested stockholder 
 or from a transaction in which a person becomes an interested stockholder                                                                 |

In general, Section 203 defines business